The Federal Register

New Animal Drugs For Use in Animal Feeds; Tylosin

Tue, Dec 12 2006 11:00:00 GMT

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health, A Division of Eli Lilly & Co. The supplemental NADA provides for an alternate feeding regimen for tylosin phosphate in Type C medicated swine feeds used for the control of swine proliferative enteropathies.

Over-the-Counter Human Drugs; Labeling Requirements; Proposed Rule

Tue, Dec 12 2006 11:00:00 GMT

The Food and Drug Administration (FDA) is proposing to amend its final rule that established standardized format and content requirements for the labeling of overthecounter (OTC) drug products (Drug Facts Rule, codified at 21 CFR 201.66). This amendment proposes a definition and the option of alternative labeling requirements for ``conveniencesize'' OTC drug packages.

Medical Devices Dispute Resolution Panel of the Medical Devices Advisory Committee; Amendment of Notice

Tue, Dec 12 2006 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Medical Devices Dispute Resolution Panel of the Medical Devices Advisory Committee. This meeting was originally announced in the Federal Register of November 24, 2006 (71 FR 67879). The amendment is being made to reflect a change in the Date and Time portion of the document, specifically, a change in the start time of the meeting. There are no other changes.